Ketanest | Analytical | Solutions | HPLC | GC | PharmaCompass.com

Please Wait

Applying Filters...

Ketanest

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 8 USDMF, 6 CEP/COS, 1 JDMF, 1 EU WC, 18 NDC API, 1 VMF, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

134 Drugs in Development

134 Drugs in Development

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 18 FDA Orange Book, 11 Europe, 8 Canada, 6 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/ML, INJECTABLE;INJECTION - EQ 10MG BASE/ML, INJECTABLE;INJECTION - EQ 50MG BASE/ML

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 3 Actylis, 1 BASF, 1 Finar, 1 Kerry, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

4 Solubilizers, 4 Parenteral, 3 Topical, 2 Emulsifying Agents, 2 Film Formers & Plasticizers, 1 Coating Systems & Additives, 1 Controlled & Modified Release, 1 Thickeners and Stabilizers

DIGITAL CONTENT

105 News #PharmaBuzz

105 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 Regulatory FDF Prices

7 Regulatory FDF Prices

MARKET PLACE

11 APIs, 7 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 2 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1YMC

filter Product Code Reset all filters

filter Classification Reset all filters

Product Main Page

01

YMC

YMC CHIRAL NEA (R)

Organic Process R&D

Not Confirmed

Contact us
to update this info